Inactive Instrument

News ALTRIA GROUP Euronext Paris

Equities

Real-time Estimate Tradegate Other stock markets 09:41:39 2024-07-16 am EDT
43.83 ^EUR	0.00%

01:09pm	Goldman Sachs Adjusts Price Target on Altria Group to $50 From $47, Maintains Buy Rating	MT
Jul. 01	A patriotic ETF	MT

Goldman Sachs Adjusts Price Target on Altria Group to $50 From $47, Maintains Buy Rating	07:09am	MT
A patriotic ETF	Jul. 01	MT
Tiny Chain Bridge is top banker to Trump, Republican campaigns	Jul. 01	RE
US urges dismissal of lawsuit seeking menthol cigarette ban	Jun. 28	RE
Altria Submits Application for On! Plus Nicotine Pouches to FDA	Jun. 26	DJ
Altria seeks FDA marketing order for oral nicotine pouch products	Jun. 26	RE
Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches	Jun. 26	BU
Altria Group, Inc. Announces PMTA Submission for On!PLUS Nicotine Pouches	Jun. 26	CI
NJOY Receives First FDA Authorizations for Menthol E-Vapor Products	Jun. 25	AQ
Altria Group, Inc. - NJOY Receives First FDA Authorizations for Menthol E-Vapor Products	Jun. 24	AQ
NJOY Receives First FDA Authorizations for Menthol E-Vapor Products	Jun. 21	BU
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers	Jun. 21	AQ
Consumer Stocks Rise As Retailers Battle Inflation -- Consumer Roundup	Jun. 21	DJ
In a first, FDA authorizes flavored vape products from Altria's NJOY for sale	Jun. 21	RE
In a first, FDA authorizes flavored e-cigarettes from Altria's NJOY for sale in the US	Jun. 21	RE
Altria Group's NJOY Gets FDA Approval to Market 4 E-Cigarettes Products	Jun. 21	MT
Deutsche Bank Adjusts Altria Group Price Target to $52 From $50, Maintains Buy Rating	Jun. 21	MT
UBS Trims Price Target on Altria to $36 From $36.50, Maintains Sell Rating	Jun. 14	MT
Ex-dividend day	Jun. 13	FA
US FDA rescinds market denial order for Juul products	Jun. 06	RE

No results for this search